Porphyria cutanea tarda and bullous dermatoses associated with chronic renal failure: a review.
D000328:Adult; D000536:Aluminum Hydroxide / Q000009:adverse effects; D005260:Female; D005665:Furosemide / Q000009:adverse effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D007688:Kidneys, Artificial; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000009:adverse effects; D010951:Plasma Exchange; D010968:Plasticizers / Q000009:adverse effects; D011164:Porphyrias / Q000209:etiology* / Q000628:therapy; D006435:Renal Dialysis / Q000009:adverse effects*; D012871:Skin Diseases / Q000209:etiology* / Q000628:therapy; D012872:Skin Diseases, Vesiculobullous / Q000209:etiology*; D014575:Uroporphyrinogen Decarboxylase / Q000378:metabolism
D010968:Plasticizers; D009268:Nalidixic Acid; D000536:Aluminum Hydroxide; D005665:Furosemide; D014575:Uroporphyrinogen Decarboxylase